Search - tctmd.com

Displaying 1 - 20 of 383

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1049: Escalating Mortality from Pulmonary Embolism in U.S Women of Reproductive Age: A Retrospective Analysis (1999–2020) with Projections to 2030

Presenter: Anum Ijaz

October 28, 2025

Presentation TCT 2025

Left Atrial Appendage Occlusion - Expanding Indications and Controversies

Presenter: Josep Rodés-Cabau

October 27, 2025

Presentation TCT 2025

Will Drug-coated Balloons Change the Interventional Approach to Complex Coronary Disease?

Presenter: Margaret B. McEntegart

October 27, 2025

Presentation TCT 2025

The Contemporary Management of Cardiogenic Shock in the Post DanGer-Shock Era?

Presenter: Jacob Eifer Moeller

October 27, 2025

Presentation TCT 2025

The Intersection of Heart Failure and Mitral Valve Disease – The Conundrum of Managing Functional Mitral Regurgitation

Presenter: Fabien Praz

October 27, 2025

Presentation TCT 2025

TCT 289: Age >65 in STEMI Cardiogenic Shock: Persistent Mortality Risk Despite PCI in a System Without Surgical or Mechanical Escalation

Presenter: Miles Chapman

October 27, 2025

Presentation TCT 2025

Optimizing Shock Escalation from Interventional Perspective

Presenter: Ramesh Mazhari

October 27, 2025

Presentation TCT 2025

DanGer Long Term Data ESC: Evidence in the Post DanGer Era

Presenter: Daniel Burkhoff

October 27, 2025

Presentation TCT 2025

TCT 272: Escalation of Mechanical Circulatory Support in non-comatose Patients with STEMI-related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial

Presenter: Norman Mangner

October 27, 2025

Presentation TCT 2025

Multivessel Disease in Patients with Stable CAD: Determining Treatment Targets through Intravascular Imaging and Physiology

Presenter: Javier Escaned

October 27, 2025

Presentation TCT 2025

TCT 1411: HFrEF: A Long-Term Journey Marked by One Narrow Escape After Another

Presenter: Sunanto Ng

October 26, 2025

Presentation ESC 2025

Duration of Dual Antiplatelet Therapy in Acute Coronary Syndromes: The DUAL-ACS Trial

Presenter: David Newby

September 03, 2025

Presentation ESC 2025

Randomized trial of evolocumab on saphenous vein graft patency following coronary artery bypass surgery: The NEWTON-CABG CardioLink-5 Trial

Presenter: Subodh Verma

September 01, 2025

Presentation ESC 2025

Dual or single antiplatelet therapy after coronary artery bypass grafting in patients with acute coronary syndrome: The TACSI trial

Presenter: Anders Jeppsson

September 01, 2025

Presentation ESC 2025

Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial

Presenter: Duk-Woo Park

August 31, 2025

Presentation ESC 2025

SWEDEPAD 1 and 2: Impact of drug-coated devices in patients with peripheral arterial disease

Presenter: Mårten Falkenberg, Joakim Nordanstig

August 31, 2025

Presentation ESC 2025

Helicobacter Pylori Screening after Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI-SWEDEHEART Trial

Presenter: Robin Hofmann

August 31, 2025

Presentation ESC 2025

Vericiguat in ambulatory patients with chronic heart failure with reduced ejection fraction: Results of the VICTOR trial

Presenter: Faiez Zannad

August 30, 2025

Presentation ESC 2025

ABC-AF study: Pragmatic registry-based randomised controlled trial of personalised treatment to reduce stroke or death in atrial fibrillation

Presenter: Jonas Oldgren

August 30, 2025

Presentation ESC 2025

DAPA ACT HF – TIMI 68: Dapagliflozin in Patients Hospitalized for Heart Failure

Presenter: David D. Berg

August 30, 2025

Advertisement

TCT 1049: Escalating Mortality from Pulmonary Embolism in U.S Women of Reproductive Age: A Retrospective Analysis (1999–2020) with Projections to 2030

Left Atrial Appendage Occlusion - Expanding Indications and Controversies

Will Drug-coated Balloons Change the Interventional Approach to Complex Coronary Disease?

The Contemporary Management of Cardiogenic Shock in the Post DanGer-Shock Era?

The Intersection of Heart Failure and Mitral Valve Disease – The Conundrum of Managing Functional Mitral Regurgitation

TCT 289: Age >65 in STEMI Cardiogenic Shock: Persistent Mortality Risk Despite PCI in a System Without Surgical or Mechanical Escalation

Optimizing Shock Escalation from Interventional Perspective

DanGer Long Term Data ESC: Evidence in the Post DanGer Era

TCT 272: Escalation of Mechanical Circulatory Support in non-comatose Patients with STEMI-related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial

Multivessel Disease in Patients with Stable CAD: Determining Treatment Targets through Intravascular Imaging and Physiology

TCT 1411: HFrEF: A Long-Term Journey Marked by One Narrow Escape After Another

Duration of Dual Antiplatelet Therapy in Acute Coronary Syndromes: The DUAL-ACS Trial

Randomized trial of evolocumab on saphenous vein graft patency following coronary artery bypass surgery: The NEWTON-CABG CardioLink-5 Trial

Dual or single antiplatelet therapy after coronary artery bypass grafting in patients with acute coronary syndrome: The TACSI trial

Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial

SWEDEPAD 1 and 2: Impact of drug-coated devices in patients with peripheral arterial disease

Helicobacter Pylori Screening after Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI-SWEDEHEART Trial

Vericiguat in ambulatory patients with chronic heart failure with reduced ejection fraction: Results of the VICTOR trial

ABC-AF study: Pragmatic registry-based randomised controlled trial of personalised treatment to reduce stroke or death in atrial fibrillation

DAPA ACT HF – TIMI 68: Dapagliflozin in Patients Hospitalized for Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content